PETREC (PErsonalized TReatment for Endometrial Carcinoma)
This is a national multicenter study conducted by the Finnish Gynecologic Oncology Group (FINGOG) established by the Finnish Society of Obstetrics and Gynaecology (SGY) for women with high-intermediate risk or high-risk endometrial carcinoma.
The purpose of the study is to compare the effectiveness of chemotherapy against the combination of chemotherapy and external pelvic radiotherapy in the treatment of high-risk cancer, and the effectiveness of internal vaginal radiotherapy against external pelvic radiotherapy in the treatment of intermediate-risk cancer.
Individual patient’s eligibility is assessed by their attending physician, who may suggest participation in the study.
Principal Investigator at HUS and in Finland: Docent Mikko Loukovaara, Women’s Hospital and Comprehensive Cancer Center